<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK435692" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK435692/" /><meta name="ncbi_pagename" content="SAMD9L-Related Ataxia-Pancytopenia Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SAMD9L-Related Ataxia-Pancytopenia Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SAMD9L-Related Ataxia-Pancytopenia Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/06/01" /><meta name="citation_author" content="Prasit Phowthongkum" /><meta name="citation_author" content="Dong-Hui Chen" /><meta name="citation_author" content="Wendy H Raskind" /><meta name="citation_author" content="Thomas Bird" /><meta name="citation_pmid" content="28570036" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK435692/" /><meta name="citation_keywords" content="Sterile alpha motif domain-containing protein 9-like" /><meta name="citation_keywords" content="SAMD9L" /><meta name="citation_keywords" content="SAMD9L-Related Ataxia-Pancytopenia Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SAMD9L-Related Ataxia-Pancytopenia Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Prasit Phowthongkum" /><meta name="DC.Contributor" content="Dong-Hui Chen" /><meta name="DC.Contributor" content="Wendy H Raskind" /><meta name="DC.Contributor" content="Thomas Bird" /><meta name="DC.Date" content="2017/06/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK435692/" /><meta name="description" content="SAMD9L-related ataxia-pancytopenia (ATXPC) syndrome is characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to marrow failure, myelodysplasia, and myeloid leukemia, sometimes associated with monosomy 7. The onset of hematologic abnormalities has been reported as early as age three months. The cytopenias in all cell lineages ranged from mild to very severe. Onset of neurologic impairment is variable. Nystagmus, dysmetria, increased deep tendon reflexes, and clonus are common. Gait impairment and other neurologic abnormalities are slowly progressive." /><meta name="og:title" content="SAMD9L-Related Ataxia-Pancytopenia Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="SAMD9L-related ataxia-pancytopenia (ATXPC) syndrome is characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to marrow failure, myelodysplasia, and myeloid leukemia, sometimes associated with monosomy 7. The onset of hematologic abnormalities has been reported as early as age three months. The cytopenias in all cell lineages ranged from mild to very severe. Onset of neurologic impairment is variable. Nystagmus, dysmetria, increased deep tendon reflexes, and clonus are common. Gait impairment and other neurologic abnormalities are slowly progressive." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK435692/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/samd9l-ap/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK435692/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE895FE6E04244210000000002A80121.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK435692_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK435692_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/drrs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/satb2-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK435692_"><span class="title" itemprop="name"><i>SAMD9L</i>-Related Ataxia-Pancytopenia Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Prasit Phowthongkum</span>, MD, <span itemprop="author">Dong-Hui Chen</span>, MD, PhD, <span itemprop="author">Wendy H Raskind</span>, MD, PhD, and <span itemprop="author">Thomas Bird</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK435692_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK435692_ai__"><div class="contrib half_rhythm"><span itemprop="author">Prasit Phowthongkum</span>, MD<div class="affiliation small">University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@twopsarp" class="oemail">moc.liamtoh@twopsarp</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Dong-Hui Chen</span>, MD, PhD<div class="affiliation small">University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@iuhdc" class="oemail">ude.wu@iuhdc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Wendy H Raskind</span>, MD, PhD<div class="affiliation small">University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@nurydnew" class="oemail">ude.wu@nurydnew</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Thomas Bird</span>, MD<div class="affiliation small">University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@zornmot" class="oemail">ude.wu@zornmot</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 1, 2017</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="samd9l-ap.Summary" itemprop="description"><h2 id="_samd9l-ap_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>SAMD9L</i>-related ataxia-pancytopenia (ATXPC) syndrome is characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to marrow failure, myelodysplasia, and myeloid leukemia, sometimes associated with <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 7. The onset of hematologic abnormalities has been reported as early as age three months. The cytopenias in all cell lineages ranged from mild to very severe. Onset of neurologic impairment is variable. Nystagmus, dysmetria, increased deep tendon reflexes, and clonus are common. Gait impairment and other neurologic abnormalities are slowly progressive.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>SAMD9L</i>-related ATXPC syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SAMD9L</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Red cell or platelet transfusions as needed for cytopenias; evaluation and treatment for additional unrelated causes of anemia; bone marrow transplantation and/or chemotherapy for myelodysplasia and leukemia; supportive management for ataxia to prevent falls and injury.</p><p><i>Surveillance:</i> Annual complete blood count with more frequent monitoring for any identified cytopenia; prompt evaluation for clinical signs or symptoms of cytopenia; annual evaluation of gait, coordination, and speech.</p><p><i>Agents/circumstances to avoid:</i> Nonsteroidal anti-inflammatory agents, anticoagulants, and thrombolytic agents are contraindicated if thrombocytopenia is present and should be used with caution given the fluctuating nature of the cytopenias; avoid alcohol and medications that cause sedation, which can increase problems with gait and coordination.</p></div><div><h4 class="inline">Genetic Counseling.</h4><p><i>SAMD9L</i>-related ATXPC syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. To date, no individuals diagnosed with <i>SAMD9L</i>-related ataxia-pancytopenia have the disorder as the result of a <i>de novo SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Each child of an individual with <i>SAMD9L</i>-related ATXPC syndrome has a 50% chance of inheriting the <i>SAMD9L</i> pathogenic variant; intrafamilial clinical variability has been observed. Once the <i>SAMD9L</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk for <i>SAMD9L</i>-related ATXPC syndrome and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="samd9l-ap.Diagnosis"><h2 id="_samd9l-ap_Diagnosis_">Diagnosis</h2><div id="samd9l-ap.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>SAMD9L</i>-related ataxia-pancytopenia (ATXPC) syndrome can be considered in an individual with any of the following clinical features, radiographic features, or family history, and suspected if more than one of these characteristics are present:</p><ul><li class="half_rhythm"><div>Cerebellar ataxia</div></li><li class="half_rhythm"><div>Variable hematopoietic cytopenias affecting one or more lineages (e.g., anemia, neutropenia, thrombocytopenia)</div></li><li class="half_rhythm"><div>Myeloid leukemia or myelodysplasia with partial or complete <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 7</div></li><li class="half_rhythm"><div>Cerebellar atrophy and white matter changes on brain MRI examination</div></li><li class="half_rhythm"><div>Family history of any of the above clinical or radiographic features</div></li></ul></div><div id="samd9l-ap.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>No formal clinical criteria for <i>SAMD9L</i>-related ATXPC syndrome have been established. The diagnosis of <i>SAMD9L</i>-related ATXPC syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SAMD9L</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK435692/table/samd9l-ap.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figsamd9lapTmoleculargenetictestingus" rid-ob="figobsamd9lapTmoleculargenetictestingus">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>SAMD9L</i>.</div><div class="half_rhythm">Note: <i>SAMD9L</i>-related ATXPC syndrome is postulated to occur through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism. Large intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> has not been reported; testing for intragenic deletion or duplication is not indicated.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SAMD9L</i> and other genes of interest (see <a href="#samd9l-ap.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="samd9l-ap.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>SAMD9L</i>-Related Ataxia-Pancytopenia Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK435692/table/samd9l-ap.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__samd9l-ap.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_samd9l-ap.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_samd9l-ap.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_samd9l-ap.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_samd9l-ap.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SAMD9L</i></td><td headers="hd_h_samd9l-ap.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_samd9l-ap.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/4 families&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_samd9l-ap.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_samd9l-ap.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="samd9l-ap.TF.1.1"><p class="no_margin">See <a href="/books/NBK435692/#samd9l-ap.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="samd9l-ap.TF.1.2"><p class="no_margin">See <a href="#samd9l-ap.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="samd9l-ap.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="samd9l-ap.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al [2016]</a></p></div></dd><dt>5. </dt><dd><div id="samd9l-ap.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al [2017]</a></p></div></dd><dt>6. </dt><dd><div id="samd9l-ap.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="samd9l-ap.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div><div id="samd9l-ap.Clinical_Characteristics"><h2 id="_samd9l-ap_Clinical_Characteristics_">Clinical Characteristics</h2><div id="samd9l-ap.Clinical_Description"><h3>Clinical Description</h3><p><i>SAMD9L</i>-related ataxia-pancytopenia (ATXPC) syndrome is a rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to marrow failure, myelodysplasia, and myeloid leukemia, sometimes associated with <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 7. Manifestations usually have onset in childhood and hematologic impairment can be severe, mimicking aplastic anemia or <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> thrombocytopenia purpura. There is marked inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> in age of onset, severity of neurologic and hematologic abnormalities, and rate of progression. Only four families with molecularly confirmed <i>SAMD9L</i>-related ATXPC syndrome in a total of 25 individuals have been described [<a class="bk_pop" href="#samd9l-ap.REF.li.1978.933">Li et al 1978</a>, <a class="bk_pop" href="#samd9l-ap.REF.li.1981.189">Li et al 1981</a>, <a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>, <a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>]; a fifth published family with a consistent <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is unavailable for molecular confirmation [<a class="bk_pop" href="#samd9l-ap.REF.daghistani.1989.108">Daghistani et al 1989</a>].</p><p><b>Hematologic manifestations.</b> Hematologic abnormalities are variable and can be intermittent. The onset of hematologic abnormalities has been reported as early as age three months.</p><p>The cytopenias in all cell lineages ranged from mild to very severe. Anemia and/or mild macrocytosis (maximum recorded mean corpuscular volume [MCV]: 108 fl) were documented in many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Immunodeficiency was documented in one family [<a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>]. Non-leukemic marrows were hypoplastic in three individuals examined. Partial or complete <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 7 was found in marrow cells from four affected individuals, one of whom eventually developed leukemia [<a class="bk_pop" href="#samd9l-ap.REF.li.1981.189">Li et al 1981</a>]; two had myelodysplasia [<a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>]. The effect of the disease on the hematopoietic system accounts for the increased mortality. In the four molecularly confirmed families, five affected individuals died in childhood from marrow failure and/or acute myeloid leukemia [<a class="bk_pop" href="#samd9l-ap.REF.li.1981.189">Li et al 1981</a>, <a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>]. Two children with myelodysplasia received matched unrelated marrow transplants and were alive 1.5 and seven years later [<a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>].</p><p>In the family suspected to have ATXPC syndrome, one of three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> people had pancytopenia at age five years with mild macrocytosis (MCV 109 fl), decreased marrow cellularity, and <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 7 identified in marrow cells. This child died from acute myeloid leukemia that developed one year following diagnosis [<a class="bk_pop" href="#samd9l-ap.REF.daghistani.1989.108">Daghistani et al 1989</a>].</p><p><b>Neurologic manifestations.</b> Neurologic involvement was observed in all individuals with <i>SAMD9L</i> pathogenic variants who were carefully examined. Two individuals with<i>SAMD9L</i> pathogenic variants were not assessed neurologically [<a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>] and one individual who was not noted to have neurologic problems during life had cerebellar atrophy detected on autopsy [<a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>]. Onset of neurologic impairment ranged from infancy to 62 years. Horizontal and vertical nystagmus and dysmetria were evident in most individuals. Deep tendon reflexes were usually increased, ankle clonus was easily elicited, and some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had extensor plantar responses [<a class="bk_pop" href="#samd9l-ap.REF.li.1978.933">Li et al 1978</a>, <a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>, <a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>]. Strength and sensation to touch and proprioception were preserved, but one individual had decreased vibration sense in the lower extremities [<a class="bk_pop" href="#samd9l-ap.REF.li.1978.933">Li et al 1978</a>]. Gait impairment and other neurologic abnormalities were slowly progressive. Some individuals eventually require a wheelchair [<a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>].</p><p>The severities of hematologic and neurologic abnormalities are not concordant. An individual who died at age 16 years from a retroperitoneal bleed secondary to thrombocytopenia had no clinically reported neurologic manifestations, despite the presence of cerebellar atrophy. Several individuals had moderate to severe neurologic involvement with only mild or undetected hematologic involvement [<a class="bk_pop" href="#samd9l-ap.REF.li.1981.189">Li et al 1981</a>, <a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>].</p><p><b>Neuroimaging and neuropathology.</b> Eight individuals with a range of neurologic manifestations have been evaluated by brain imaging or autopsy. Marked cerebellar atrophy and loss of Purkinje cells were detected in four individuals, age seven to 16 years, in two families whose brains were examined postmortem. Moderate loss of neurons in the inferior olives and central nuclei was noted in two of these individuals [<a class="bk_pop" href="#samd9l-ap.REF.li.1981.189">Li et al 1981</a>, <a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>]. CT imaging of two of these children and their father revealed moderate to marked cerebellar atrophy at a time when their ataxia was described as mild to moderate [<a class="bk_pop" href="#samd9l-ap.REF.li.1981.189">Li et al 1981</a>]. At age 54 years, the surviving sib in this family had moderately severe ataxia and required a walker to ambulate. Brain MRI at age 52 years showed severe diffuse cerebellar atrophy as well as diffuse bilateral white matter signals throughout the cerebrum [<a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>].</p><p>In the second family reported by <a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al [2016]</a>, brain MRIs revealed marked cerebellar degeneration, pronounced in the midline, in a man age 32 years with severe ataxia, and moderate midline cerebellar atrophy in his sister age 38 years, who had only mild clinical manifestations. Cerebellar atrophy and white matter abnormalities were also noted on MRI of two individuals reported by <a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al [2017]</a>.</p></div><div id="samd9l-ap.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>As only four families with identified pathogenic variants in <i>SAMD9L</i> have been reported, it is not possible to determine if there are <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>. Two of six <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK435692/table/samd9l-ap.T.samd9l_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figsamd9lapTsamd9lpathogenicvariantsd" rid-ob="figobsamd9lapTsamd9lpathogenicvariantsd">p.Cys1196Ser</a> [<a class="bk_pop" href="#samd9l-ap.REF.li.1978.933">Li et al 1978</a>, <a class="bk_pop" href="#samd9l-ap.REF.li.1981.189">Li et al 1981</a>] and none of 17 with any of the other three known pathogenic variants [<a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>] have developed acute leukemia to date, but this tally does not include the two individuals who received marrow transplantation for myelodysplasia [<a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>]. Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for loss of the <i>SAMD9L</i> pathogenic variant has been documented in hematopoietic tissues of some individuals in three of the families [<a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>, <a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>]. It is speculated that the presence of a clone that has <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> for the normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> may ameliorate the severity of the hematologic manifestations [<a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>].</p></div><div id="samd9l-ap.Penetrance"><h3>Penetrance</h3><p>To date, all 24 carefully assessed <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in the four families with pathogenic variants in <i>SAMD9L</i> exhibited clinical manifestations. One individual without hematologic cytopenias was not neurologically examined. Expressivity of both hematologic and neurologic manifestations is extremely variable and shows no difference for males and females.</p></div><div id="samd9l-ap.Nomenclature"><h3>Nomenclature</h3><p>The disorder was initially called myelocerebellar syndrome by <a class="bk_pop" href="#samd9l-ap.REF.li.1978.933">Li et al [1978]</a>.</p></div><div id="samd9l-ap.Prevalence"><h3>Prevalence</h3><p>True prevalence is unknown, but the disorder is extremely rare. To the authors' knowledge, only four families with molecularly confirmed ataxia-pancytopenia syndrome have been described in the scientific literature [<a class="bk_pop" href="#samd9l-ap.REF.li.1978.933">Li et al 1978</a>, <a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>, <a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>].</p></div></div><div id="samd9l-ap.Genetically_Related_Allelic_Di"><h2 id="_samd9l-ap_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>SAMD9L</i>.</p></div><div id="samd9l-ap.Differential_Diagnosis"><h2 id="_samd9l-ap_Differential_Diagnosis_">Differential Diagnosis</h2><p>As with other ataxias, it is important to consider acquired causes, as they may be amenable to targeted treatment, and other inherited cerebellar ataxias, as there is considerable overlap in neurologic manifestations (see <a href="/books/n/gene/ataxias/">Ataxia Overview</a>).</p><p>Because the prominent medical problem in many individuals with ATXPC syndrome is hematopoietic cytopenias, and neurologic impairment may be minimal, acquired bone marrow failure syndromes such as aplastic anemia or <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> thrombocytopenia purpura would also be included in the differential diagnosis.</p><div id="samd9l-ap.T.disorders_to_consider_in_the" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>SAMD9L</i>-Related Ataxia-Pancytopenia Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK435692/table/samd9l-ap.T.disorders_to_consider_in_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__samd9l-ap.T.disorders_to_consider_in_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hematologic Manifestations</th><th id="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic Manifestations</th><th id="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr></thead><tbody><tr><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sider-anemia/">X-linked sideroblastic anemia and ataxia</a></td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCB7</i></td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Moderate hypochromic &#x00026; microcytic anemia w/out progression to marrow failure</div></li><li class="half_rhythm"><div>Not associated w/malignancy</div></li></ul>
</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spinocerebellar syndrome in males&#x000a0;<sup>1</sup></td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ataxia-telangiectas/">Ataxia-telangiectasia</a></td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ATM</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Bone marrow failure</div></li><li class="half_rhythm"><div>Increased risk for malignancy, particularly lymphocytic leukemia &#x00026; lymphoma</div></li></ul>
</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive cerebellar ataxia, oculomotor apraxia, choreoathetosis</div></li><li class="half_rhythm"><div>Early-onset dystonia in non-classic form</div></li></ul>
</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Immunodeficiency</div></li><li class="half_rhythm"><div>Sensitivityto ionizing radiation</div></li><li class="half_rhythm"><div>Telangiectasias</div></li></ul>
</td></tr><tr><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fa/">Fanconi anemia</a></td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD<br />XL</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive bone marrow failure</div></li><li class="half_rhythm"><div>Myelodysplasia</div></li><li class="half_rhythm"><div>Acute myeloid leukemia</div></li></ul>
</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Ophthalmic abnormalities</div></li></ul>
</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Solid tumors</div></li><li class="half_rhythm"><div>Congenital abnormalities&#x000a0;<sup>3</sup></div></li><li class="half_rhythm"><div>Chromosome breakage/radial forms on lymphocyte <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> testing w/DEB &#x00026; MMC</div></li></ul>
</td></tr><tr><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dkc/">Dyskeratosis congenita</a></td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL<br />AD<br />AR</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive bone marrow failure</div></li><li class="half_rhythm"><div>Myelodysplasia</div></li><li class="half_rhythm"><div>Acute myeloid leukemia</div></li></ul>
</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal psychomotor development &#x00026; neurologic function in most persons; see footnote 5 for exceptions</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dysplastic nails</div></li><li class="half_rhythm"><div>Lacy reticular pigmentation</div></li><li class="half_rhythm"><div>Oral leukoplakia</div></li><li class="half_rhythm"><div>Squamous cell carcinomas</div></li><li class="half_rhythm"><div>Other solid tumors</div></li><li class="half_rhythm"><div>Pulmonary fibrosis</div></li></ul>
</td></tr><tr><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mono7-mds/">Familial monosomy 7 syndrome</a></td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">n/a</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Bone marrow insufficiency/failure</div></li><li class="half_rhythm"><div>Acute myeloid leukemia</div></li><li class="half_rhythm"><div>Myelodysplasia</div></li></ul>
</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MIRAGE syndrome (OMIM <a href="http://www.omim.org/entry/617053" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617053</a>)</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SAMD9</i></td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Myelodysplasia</div></li><li class="half_rhythm"><div>Cytopenias</div></li></ul>
</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment</td><td headers="hd_h_samd9l-ap.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Adrenal hypoplasia</div></li><li class="half_rhythm"><div>Growth restriction</div></li><li class="half_rhythm"><div>Enteropathy</div></li><li class="half_rhythm"><div>Genital abnormalities</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; DEB = diepoxybutane; MMC = mitomycin C; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="samd9l-ap.TF.2.1"><p class="no_margin">Spinocerebellar syndrome in males manifest primarily as delayed walking, ataxia evident in early childhood, dysmetria, and dysdiadochokinesis. When present the intention tremor is mild and the dysarthria is mild to moderately severe. The ataxia has been described as either non-progressive or slowly progressive.</p></div></dd><dt>2. </dt><dd><div id="samd9l-ap.TF.2.2"><p class="no_margin">Genes known to be associated with Fanconi anemia include <i>BRCA2</i>, <i>BRIP1</i>, <i>FANCA</i>, <i>FANCB</i>, <i>FANCC</i>, <i>FANCD2</i>, <i>FANCE</i>, <i>FANCF</i>, <i>FANCG</i>, <i>FANCI</i>, <i>FANCL</i>, <i>FANCM</i>, <i>PALB2</i>, <i>RAD51C</i>, <i>SLX4</i>, and <i>UBE2T</i>.</p></div></dd><dt>3. </dt><dd><div id="samd9l-ap.TF.2.3"><p class="no_margin">The majority of individuals with FA have <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> abnormalities, most commonly short stature and skeletal, craniofacial, and genitourinary tract malformations. Abnormal skin pigmentation and microcephaly are also common. Other anomalies include developmental delay, hearing loss, congenital heart disease, and CNS anomalies.</p></div></dd><dt>4. </dt><dd><div id="samd9l-ap.TF.2.4"><p class="no_margin">To date, <i>ACD</i>, <i>CTC1</i>, <i>DKC1</i>, <i>NHP2</i>, <i>NOP10</i>, <i>PARN</i>, <i>RTEL1</i>, <i>TERC</i>, <i>TERT</i>, <i>TINF2</i>, and <i>WRAP53</i> are the genes in which pathogenic variants are known to cause dyskeratosis congenita.</p></div></dd><dt>5. </dt><dd><div id="samd9l-ap.TF.2.5"><p class="no_margin">Significant developmental delay is present in the two clinical variants &#x02013; Hoyeraal-Hreidarsson syndrome and Revesz syndrome &#x02013; in which additional findings include, respectively: cerebellar hypoplasia and ataxia; and bilateral exudative retinopathy and intracranial calcifications.</p></div></dd></dl></div></div></div></div><div id="samd9l-ap.Management"><h2 id="_samd9l-ap_Management_">Management</h2><div id="samd9l-ap.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>SAMD9L</i>-related ataxia-pancytopenia (ATXPC) syndrome, the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Medical history and physical examination including neurologic examination</div></li><li class="half_rhythm"><div>Brain MRI examination and referral to a neurologist</div></li><li class="half_rhythm"><div>Complete blood count with differential</div></li><li class="half_rhythm"><div>Referral to a hematologist/oncologist; bone marrow examination including <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7-targeted <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> if hematologic abnormalities are more than minimal</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="samd9l-ap.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Hematologic manifestations</b></p><ul><li class="half_rhythm"><div>Management of hematologic impairment is based on the severity of cytopenias and consists of red cell or platelet transfusions as needed.</div></li><li class="half_rhythm"><div>Evaluate and treat for unrelated causes of anemia such as iron and vitamin deficiencies.</div></li><li class="half_rhythm"><div>Marrow transplantation for myelodysplasia was successful in two individuals to date.</div></li></ul><p>Note: There are no data to support use of erythropoietin or granulocyte-stimulating factor in <i>SAMD9L</i>-related ATXPC syndrome; these growth factors may increase the risk for myelodysplasia and myeloid leukemia.</p><p><b>Neurologic manifestations.</b> Management of ataxia is supportive, as there is no known therapy to delay or halt the progression of the disease.</p><ul><li class="half_rhythm"><div>Individuals should continue to be active and use canes and walkers to prevent falls.</div></li><li class="half_rhythm"><div>Modification of the home with such conveniences as grab bars, raised toilet seats, and ramps to accommodate motorized chairs may be necessary.</div></li><li class="half_rhythm"><div>Weight control is important because obesity can exacerbate difficulties with ambulation and mobility.</div></li></ul></div><div id="samd9l-ap.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Complete blood count annually. If cytopenias are identified, these should be monitored more frequently.</div></li><li class="half_rhythm"><div>Patient/family education to seek prompt clinical evaluation if any signs or symptoms suggestive of hematopoietic cytopenia develop (e.g., fatigue, pallor, unexpected bleeding, recurrent infections).</div></li><li class="half_rhythm"><div>Annual evaluation of gait, coordination, and speech.</div></li></ul></div><div id="samd9l-ap.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Nonsteroidal anti-inflammatory agents, anticoagulants, and thrombolytic agents are contraindicated if thrombocytopenia is present and should be used with caution given the fluctuating nature of the cytopenias.</p><p>Avoid consuming alcohol and medications that cause sedation, which can increase problems with gait and coordination.</p></div><div id="samd9l-ap.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the <i>SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family in order to identify as early as possible those who would benefit from hematologic surveillance and prompt initiation of treatment for severe cytopenias and myelodysplasia.</p><p>See <a href="#samd9l-ap.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="samd9l-ap.Pregnancy_Management"><h3>Pregnancy Management</h3><p>There is no information of the effect of pregnancy on manifestations of <i>SAMD9L-</i>related ATXPC syndrome. Anemia, thrombocytopenia, or neutropenia may increase the risk of pregnancy complications.</p></div><div id="samd9l-ap.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="samd9l-ap.Genetic_Counseling"><h2 id="_samd9l-ap_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="samd9l-ap.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>SAMD9L</i>-related ataxia-pancytopenia (ATXPC) syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="samd9l-ap.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (for whom relevant parental information was available) in the four families with confirmed <i>SAMD9L</i>-related ATXPC syndrome have an affected parent. Marked intrafamilial variation in terms of age of onset, neurologic manifestations, and hematologic abnormalities is reported in all of these families.</div></li><li class="half_rhythm"><div>To date, no individuals diagnosed with <i>SAMD9L</i>-related ATXPC syndrome have the disorder as the result of a <i>de novo SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of apparently asymptomatic parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> include <i>SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>Theoretically, the family history of an individual diagnosed with <i>SAMD9L</i>-related ATXPC syndrome may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Although not yet definitively observed, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is possible. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%. Intrafamilial clinical variability has been observed (see <a href="#samd9l-ap.Clinical_Description">Clinical Description</a>).</div></li><li class="half_rhythm"><div>If the <i>SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population because of the possibility of either parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for the <i>SAMD9L</i> pathogenic variant or parental <a class="def" href="/books/n/gene/glossary/def-item/revertant-mosaicism/">revertant mosaicism</a> for loss of the <i>SAMD9L</i> pathogenic variant (see <a href="#samd9l-ap.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>SAMD9L</i>-related ATXPC syndrome has a 50% chance of inheriting the <i>SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; intrafamilial clinical variability has been observed (see <a href="#samd9l-ap.Clinical_Description">Clinical Description</a>).</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="samd9l-ap.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#samd9l-ap.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="samd9l-ap.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SAMD9L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <i>SAMD9L</i>-related ATXPC syndrome are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="samd9l-ap.Resources"><h2 id="_samd9l-ap_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Aplastic Anemia &#x00026; MDS International Foundation, Inc.</b></div><div>100 Park Avenue</div><div>Suite 108</div><div>Rockville MD 20850</div><div><b>Phone:</b> 800-747-2820; 301-279-7202</div><div><b>Fax:</b> 301-279-7205</div><div><b>Email:</b> help@aamds.org; info@aamds.org</div><div><a href="http://www.aamds.org/about-us" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aamds.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li></ul></div><div id="samd9l-ap.Molecular_Genetics"><h2 id="_samd9l-ap_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="samd9l-ap.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SAMD9L-Related Ataxia-Pancytopenia Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK435692/table/samd9l-ap.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__samd9l-ap.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_samd9l-ap.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_samd9l-ap.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_samd9l-ap.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_samd9l-ap.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_samd9l-ap.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_samd9l-ap.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/219285" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SAMD9L</i></a></td><td headers="hd_b_samd9l-ap.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=219285" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_samd9l-ap.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8IVG5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sterile alpha motif domain-containing protein 9-like</a></td><td headers="hd_b_samd9l-ap.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SAMD9L" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SAMD9L</a></td><td headers="hd_b_samd9l-ap.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SAMD9L[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SAMD9L</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="samd9l-ap.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="samd9l-ap.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SAMD9L-Related Ataxia-Pancytopenia Syndrome (<a href="/omim/159550,611170" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK435692/table/samd9l-ap.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__samd9l-ap.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/159550" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">159550</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATAXIA-PANCYTOPENIA SYNDROME; ATXPC</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611170" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611170</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9-LIKE; SAMD9L</td></tr></tbody></table></div></div><div id="samd9l-ap.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>The role of SAMD9L in human bone marrow failure and malignancies is not known with certainty. Many lines of evidence showed that SAMD9L has a role in cell proliferation, most likely as a tumor suppressor. The levels of expression of SAMD9L in breast cancer tissue and hepatocellular carcinomas are lower than in normal breast or liver tissue from the same individuals [<a class="bk_pop" href="#samd9l-ap.REF.li.2007.92">Li et al 2007</a>, <a class="bk_pop" href="#samd9l-ap.REF.wang.2014.807">Wang et al 2014</a>]. Somatic pathogenic variants clustered in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of <i>SAMD9L</i> have been identified in hepatitis-B-related hepatocellular carcinomas [<a class="bk_pop" href="#samd9l-ap.REF.huang.2012.1117">Huang et al 2012</a>, <a class="bk_pop" href="#samd9l-ap.REF.wang.2014.807">Wang et al 2014</a>]. There is enhanced proliferation and colony formation of multiple hepatocellular carcinoma cell lines and increased tumorigenicity in nude mice after knockdown of <i>Samd9l</i>, the ortholog of <i>SAMD9L</i>, by siRNA or shRNA [<a class="bk_pop" href="#samd9l-ap.REF.wang.2014.807">Wang et al 2014</a>]. Loss of one or both copies of <i>Samd9l</i> predisposed the mice to develop myelodysplasia [<a class="bk_pop" href="#samd9l-ap.REF.nagamachi.2013.305">Nagamachi et al 2013</a>]. Studies in EBV-transformed leukocyte cell lines [<a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>] and transiently transfected HEK293 cells [<a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>] provided evidence that cells diploid for wild type <i>SAMD9L</i> have a selective culture advantage over those <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for mutated <i>SAMD9L</i>. The detection in multiple <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in three families of hematopoietic clones with copy-neutral <a class="def" href="/books/n/gene/glossary/def-item/loss-of-heterozygosity/">loss of heterozygosity</a> for the mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> supports a survival advantage in vivo as well [<a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>, <a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>]. The fact that the four known pathogenic variants in SAMD9L are not in the sterile alpha motif <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> suggests that the pathogenesis of <i>SAMD9L</i>-related ataxia-pancytopenia (ATXPC) syndrome is not driven by the sterile alpha motif.</p><p>In individuals with <i>SAMD9L</i>-related ATXPC syndrome, marrow hypocellularity without dysplastic features reflects a toxic gain of function with suppression of precursor cell divisions. In contrast, consistent with what was observed in mice, <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> for SAMD9L through <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> of 7 or 7q predisposed to myelodysplasia [<a class="bk_pop" href="#samd9l-ap.REF.li.2012.554">Li et al 2012</a>, <a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>]. Interestingly, loss of the mutated <i>SAMD9</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> via monosomy 7 led to myelodysplasia in two individuals with MIRAGE syndrome [<a class="bk_pop" href="#samd9l-ap.REF.narumi.2016.792">Narumi et al 2016</a>]. It is speculated that transformation to acute myeloid leukemia requires additional mutations.</p><p>The neurologic component of <i>SAMD9L</i>-related ATXPC syndrome possibly results from a toxic gain of function, given that neurologic deficits were not described and presumably not present in <i>Samd9l</i> knockout mice [<a class="bk_pop" href="#samd9l-ap.REF.li.2012.554">Li et al 2012</a>, <a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>].</p><p><b>Gene structure.</b>
<i>SAMD9L</i> encompasses 18 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. The longest transcript variant <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_152703.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_152703.3</a> has five exons, but exons 1-4 are noncoding.</p><p>Interestingly, <i>SAMD9L</i> is contiguous to paralogous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>SAMD9</i>, in which defects cause the unrelated syndromes normophosphatemic <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> tumoral calcinosis (OMIM <a href="http://www.omim.org/entry/610455" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610455</a>) [<a class="bk_pop" href="#samd9l-ap.REF.topaz.2006.759">Topaz et al 2006</a>] and the MIRAGE syndrome (OMIM <a href="http://www.omim.org/entry/617053" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617053</a>) [<a class="bk_pop" href="#samd9l-ap.REF.narumi.2016.792">Narumi et al 2016</a>].</p><p><b>Pathogenic variants.</b> Four pathogenic variants, <a class="figpopup" href="/books/NBK435692/table/samd9l-ap.T.samd9l_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figsamd9lapTsamd9lpathogenicvariantsd" rid-ob="figobsamd9lapTsamd9lpathogenicvariantsd">c.2640C&#x0003e;A</a>, <a class="figpopup" href="/books/NBK435692/table/samd9l-ap.T.samd9l_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figsamd9lapTsamd9lpathogenicvariantsd" rid-ob="figobsamd9lapTsamd9lpathogenicvariantsd">c.3587G&#x0003e;C</a>, <a class="figpopup" href="/books/NBK435692/table/samd9l-ap.T.samd9l_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figsamd9lapTsamd9lpathogenicvariantsd" rid-ob="figobsamd9lapTsamd9lpathogenicvariantsd">c.2672T&#x0003e;C</a>, and <a class="figpopup" href="/books/NBK435692/table/samd9l-ap.T.samd9l_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figsamd9lapTsamd9lpathogenicvariantsd" rid-ob="figobsamd9lapTsamd9lpathogenicvariantsd">c.2956C&#x0003e;T</a>, have been identified to date, each in a single family [<a class="bk_pop" href="#samd9l-ap.REF.chen.2016.1146">Chen et al 2016</a>, <a class="bk_pop" href="#samd9l-ap.REF.tesi.2017.2266">Tesi et al 2017</a>].</p><div id="samd9l-ap.T.samd9l_pathogenic_variants_d" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>SAMD9L</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK435692/table/samd9l-ap.T.samd9l_pathogenic_variants_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__samd9l-ap.T.samd9l_pathogenic_variants_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2640C&#x0003e;A</td><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His880Gln</td><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_152703.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_152703<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_689916.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_689916<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2672T&#x0003e;C</td><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile891Thr</td></tr><tr><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2956C&#x0003e;T</td><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg986Cys</td></tr><tr><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3587G&#x0003e;C</td><td headers="hd_h_samd9l-ap.T.samd9l_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys1196Ser</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The 7.1 kb <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> of transcript variant <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_152703.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_152703.3</a> encodes 1,584 amino acids. Amino acids 14 to 79 comprise the sterile alpha motif <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> It is postulated that the four known pathogenic variants increase the function of SAMD9L protein to suppress normal hematopoiesis. The neurologic component of <i>SAMD9L</i>-related ATXPC syndrome possibly results from a toxic gain of function (see <a href="#samd9l-ap.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</a>).</p></div></div><div id="samd9l-ap.References"><h2 id="_samd9l-ap_References_">References</h2><div id="samd9l-ap.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.chen.2016.1146">Chen DH, Below JE, Shimamura A, Keel SB, Matsushita M, Wolff J, Sul Y, Bonkowski E, Castella M, Taniguchi T, Nickerson D, Papayannopoulou T, Bird TD, Raskind WH. Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L. <span><span class="ref-journal">Am J Hum Genet. </span>2016;<span class="ref-vol">98</span>:1146–58.</span> [<a href="/pmc/articles/PMC4908176/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4908176</span></a>] [<a href="/pubmed/27259050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27259050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.daghistani.1989.108">Daghistani D, Curless R, Toledano SR, Ayyar DR. Ataxia-pancytopenia and monosomy 7 syndrome. <span><span class="ref-journal">J Pediatr. </span>1989;<span class="ref-vol">115</span>:108–10.</span> [<a href="/pubmed/2738778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2738778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.huang.2012.1117">Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, Zhu ZD, Zhou B, Liu XY, Liu RF, Fei QL, Chen H, Cai B, Zhou B, Xiao HS, Qin LX, Han ZG. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1117–21.</span> [<a href="/pubmed/22922871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22922871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.li.2007.92">Li CF, Macdonald JR, Wei RY, Ray J, Lau K, Kandel C, Koffman R, Bell S, Scherer SW, Alman BA. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse. <span><span class="ref-journal">BMC Genomics. </span>2007;<span class="ref-vol">8</span>:92.</span> [<a href="/pmc/articles/PMC1855325/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1855325</span></a>] [<a href="/pubmed/17407603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17407603</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.li.1981.189">Li FP, Hecht F, Kaiser-Mccaw B, Baranko PV, Potter NU. Ataxia-pancytopenia: syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia. <span><span class="ref-journal">Cancer Genet Cytogenet. </span>1981;<span class="ref-vol">4</span>:189–96.</span> [<a href="/pubmed/6947857" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6947857</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.li.1978.933">Li FP, Potter NU, Buchanan GR, Vawter G, Whang-Peng J, Rosen RB. A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy. <span><span class="ref-journal">Am J Med. </span>1978;<span class="ref-vol">65</span>:933–40.</span> [<a href="/pubmed/283689" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 283689</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.li.2012.554">Li Q, Guo H, Matsui H, Honda H, Inaba T, Sundberg JP, Sprecher E, Uitto J. Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis. <span><span class="ref-journal">Exp Dermatol. </span>2012;<span class="ref-vol">21</span>:554–6.</span> [<a href="/pmc/articles/PMC3381902/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3381902</span></a>] [<a href="/pubmed/22716256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22716256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.nagamachi.2013.305">Nagamachi A, Matsui H, Asou H, Ozaki Y, Aki D, Kanai A, Takubo K, Suda T, Nakamura T, Wolff L, Honda H, Inaba T. Haploinsufficiency of SAMD9L, an endosome fusion facilitator causes myeloid malignancies in mice mimicking human diseases with monosomy 7. <span><span class="ref-journal">Cancer Cell. </span>2013;<span class="ref-vol">24</span>:305–17.</span> [<a href="/pubmed/24029230" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24029230</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.narumi.2016.792">Narumi S, Amano N, Ishii T, Katsumata N, Muroya K, Adachi M, Toyoshima K, Tanaka Y, Fukuzawa R, Miyako K, Kinjo S, Ohga S, Ihara K, Inoue H, Kinjo T, Hara T, Kohno M, Yamada S, Urano H, Kitagawa Y, Tsugawa K, Higa A, Miyawaki M, Okutani T, Kizaki Z, Hamada H, Kihara M, Shiga K, Yamaguchi T, Kenmochi M, Kitajima H, Fukami M, Shimizu A, Kudoh J, Shibata S, Okano H, Miyake N, Matsumoto N, Hasegawa T. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:792–7.</span> [<a href="/pubmed/27182967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27182967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.tesi.2017.2266">Tesi B, Davidsson J, Voss M, Rahikkala E, Holmes TD, Chiang SCC, Komulainen-Ebrahim J, Gorcenco S, Rundberg Nilsson A, Ripperger T, Kokkonen H, Bryder D, Fioretos T, Henter JI, M&#x000f6;tt&#x000f6;nen M, Niinim&#x000e4;ki R, Nilsson L, Pronk CJ, Puschmann A, Qian H, Uusimaa J, Moilanen J, Tedg&#x000e5;rd U, Cammenga J, Bryceson YT. Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. <span><span class="ref-journal">Blood. </span>2017;<span class="ref-vol">129</span>:2266–79.</span> [<a href="/pmc/articles/PMC5399482/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5399482</span></a>] [<a href="/pubmed/28202457" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28202457</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.topaz.2006.759">Topaz O, Indelman M, Chefetz I, Geiger D, Metzker A, Altschuler Y, Choder M, Bercovich D, Uitto J, Bergman R, Richard G, Sprecher E. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:759–64.</span> [<a href="/pmc/articles/PMC1592555/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1592555</span></a>] [<a href="/pubmed/16960814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16960814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="samd9l-ap.REF.wang.2014.807">Wang Q, Zhai YY, Dai JH, Li KY, Deng Q, Han ZG. SAMD9L inactivation promotes cell proliferation via facilitating G1-S transition in hepatitis B virus-associated hepatocellular carcinoma. <span><span class="ref-journal">Int J Biol Sci. </span>2014;<span class="ref-vol">10</span>:807–16.</span> [<a href="/pmc/articles/PMC4115192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4115192</span></a>] [<a href="/pubmed/25076857" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25076857</span></a>]</div></li></ul></div><div id="samd9l-ap.Author_Notes"><h3>Author Notes</h3><p>Website: <a href="http://www.gs.washington.edu/faculty/raskind.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.gs.washington.edu/faculty/raskind.htm</a></p><p>The focus of research in the Raskind laboratory is to find and study genes responsible for inherited neurologic disorders. In a long-standing collaboration with Dr. Thomas Bird, we identified <i>ABCB7</i> for <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> sideroblastic anemia with ataxia, <i>PRKCG</i> for SCA14, <i>ATP6AP2</i> for X-linked parkinsonism with spasticity, and <i>ADCY5</i> for <i>ADCY5</i>-related dyskinesia, in addition to <i>SAMD9L</i> for ATXPC syndrome.</p></div><div id="samd9l-ap.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 June 2017 (sw) Review posted live</div></li><li class="half_rhythm"><div>5 December 2016 (wr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK435692</span><span class="label">PMID: <a href="/pubmed/28570036" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">28570036</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/drrs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/satb2-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK435692&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK435692/?report=reader">PubReader</a></li><li><a href="/books/NBK435692/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK435692" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK435692" style="display:none" title="Cite this Page"><div class="bk_tt">Phowthongkum P, Chen DH, Raskind WH, et al. SAMD9L-Related Ataxia-Pancytopenia Syndrome. 2017 Jun 1. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK435692/pdf/Bookshelf_NBK435692.pdf">PDF version of this page</a> (181K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#samd9l-ap.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#samd9l-ap.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#samd9l-ap.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#samd9l-ap.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#samd9l-ap.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#samd9l-ap.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#samd9l-ap.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#samd9l-ap.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#samd9l-ap.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#samd9l-ap.References" ref="log$=inpage&amp;link_id=inpage">References</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=219285[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SAMD9L</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4399908" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4399908" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4399908" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4399908" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28852709" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Ataxia-pancytopenia syndrome with &lt;i&gt;SAMD9L&lt;/i&gt; mutations.</a><span class="source">[Neurol Genet. 2017]</span><div class="brieflinkpop offscreen_noflow">Ataxia-pancytopenia syndrome with &lt;i&gt;SAMD9L&lt;/i&gt; mutations.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gorcenco S, Komulainen-Ebrahim J, Nordborg K, Suo-Palosaari M, Andréasson S, Krüger J, Nilsson C, Kjellström U, Rahikkala E, Turkiewicz D, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurol Genet. 2017 Oct; 3(5):e183. Epub 2017 Aug 24.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301722" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shwachman-Diamond Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shwachman-Diamond Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nelson A, Myers K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27259050" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.</a><span class="source">[Am J Hum Genet. 2016]</span><div class="brieflinkpop offscreen_noflow">Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen DH, Below JE, Shimamura A, Keel SB, Matsushita M, Wolff J, Sul Y, Bonkowski E, Castella M, Taniguchi T, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2016 Jun 2; 98(6):1146-1158. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29535429" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.</a><span class="source">[Leukemia. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Davidsson J, Puschmann A, Tedgård U, Bryder D, Nilsson L, Cammenga J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Leukemia. 2018 May; 32(5):1106-1115. Epub 2018 Feb 25.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301496" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Sideroblastic Anemia and Ataxia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Sideroblastic Anemia and Ataxia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bekri S, D'Hooghe M, Vermeersch P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=28570036" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=28570036" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04295a39a66ee2ba9d1a8a">SAMD9L-Related Ataxia-Pancytopenia Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SAMD9L-Related Ataxia-Pancytopenia Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:30:34-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE895FE6E04244210000000002A80121&amp;ncbi_session=CE895FE6E04295A1_0680SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK435692%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK435692&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK435692/&amp;ncbi_pagename=SAMD9L-Related Ataxia-Pancytopenia Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE895FE6E04295A1_0680SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>